Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye. But…
Companies that treat AI governance as a compliance checkbox rather than a continuous operational discipline are quietly accumulating risks their boards don’t yet know exist.
Most CEOs pursue brand partnerships before they’re ready for them. Here’s what I learned building collaborations with Reebok, Eddie Bauer and Nautica while running a publicly traded company.